Departments of1Neurological Surgery and.
2Neurology.
J Neurosurg. 2018 Feb;128(2):605-616. doi: 10.3171/2016.11.JNS161162. Epub 2017 Apr 14.
OBJECTIVE Dysfunction of distributed neural networks underlies many brain disorders. The development of neuromodulation therapies depends on a better understanding of these networks. Invasive human brain recordings have a favorable temporal and spatial resolution for the analysis of network phenomena but have generally been limited to acute intraoperative recording or short-term recording through temporarily externalized leads. Here, the authors describe their initial experience with an investigational, first-generation, totally implantable, bidirectional neural interface that allows both continuous therapeutic stimulation and recording of field potentials at multiple sites in a neural network. METHODS Under a physician-sponsored US Food and Drug Administration investigational device exemption, 5 patients with Parkinson's disease were implanted with the Activa PC+S system (Medtronic Inc.). The device was attached to a quadripolar lead placed in the subdural space over motor cortex, for electrocorticography potential recordings, and to a quadripolar lead in the subthalamic nucleus (STN), for both therapeutic stimulation and recording of local field potentials. Recordings from the brain of each patient were performed at multiple time points over a 1-year period. RESULTS There were no serious surgical complications or interruptions in deep brain stimulation therapy. Signals in both the cortex and the STN were relatively stable over time, despite a gradual increase in electrode impedance. Canonical movement-related changes in specific frequency bands in the motor cortex were identified in most but not all recordings. CONCLUSIONS The acquisition of chronic multisite field potentials in humans is feasible. The device performance characteristics described here may inform the design of the next generation of totally implantable neural interfaces. This research tool provides a platform for translating discoveries in brain network dynamics to improved neurostimulation paradigms. Clinical trial registration no.: NCT01934296 (clinicaltrials.gov).
分布神经网络的功能障碍是许多脑部疾病的基础。神经调节疗法的发展取决于对这些网络的更好理解。侵入性人脑记录具有分析网络现象的有利的时间和空间分辨率,但通常仅限于急性术中记录或通过暂时外部化的导联进行短期记录。在这里,作者描述了他们在一种具有探索性、第一代、完全可植入、双向神经接口的初步经验,该接口允许在神经网络的多个部位连续进行治疗性刺激和场电位记录。
在医生赞助的美国食品和药物管理局调查设备豁免下,5 名帕金森病患者被植入 Activa PC+S 系统(美敦力公司)。该设备连接到一个放置在运动皮层上方的硬膜下空间中的四极导联,用于脑电图记录,以及一个放置在丘脑底核(STN)中的四极导联,用于治疗性刺激和局部场电位记录。每个患者的脑记录在 1 年内的多个时间点进行。
没有严重的手术并发症或深部脑刺激治疗中断。尽管电极阻抗逐渐增加,但大脑皮层和 STN 中的信号随时间相对稳定。在大多数但不是所有记录中都确定了运动皮层中特定频带的典型运动相关变化。
在人类中获取慢性多部位场电位是可行的。这里描述的设备性能特征可能为下一代完全可植入神经接口的设计提供信息。该研究工具为将脑网络动力学的发现转化为改进的神经刺激范式提供了一个平台。临床试验注册号:NCT01934296(clinicaltrials.gov)。